關於「ABILIFY MAINTENA」標籤，搜尋引擎有相關的訊息討論：

【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General Hospital。

ABILIFY MAINTENA的建議起始和維持劑量為每個月400毫克( 至少在前一次注射的26天後投與下一個劑量)。

對從未使用過aripiprazole的患者，建議在開始使用ABILIFY MAINTENA ...： 。

Schizophrenia Treatment – ABILIFY MAINTENA® (aripiprazole)。

You should continue to take your current antipsychotic medication for 2 weeks after your first treatment with ABILIFY MAINTENA. ABILIFY MAINTENA is an injection ...： 。

Abilify Maintena (Aripiprazole Extended-Release Injectable ... - RxList。

Abilify Maintena (Aripiprazole Extended-Release Injectable Suspension) may treat, side effects, dosage, drug interactions, warnings, patient labeling, ...： 。

Aripiprazole once-monthly 400 mg for long-term maintenance ...。

2015年11月4日 · Long-term maintenance treatment with an antipsychotic is often required to prevent relapse and mitigate functional deterioration in patients ...。

Initiation of aripiprazole once-monthly in patients with schizophrenia。

Pharmacokinetic data support 400 mg as the starting and maintenance dose of AOM; the plasma concentration profile of aripiprazole after initiating AOM 400 ...。

Abilify Maintena 400 mg powder and solvent for prolonged-release ...。

Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) ...： 。

Abilify Maintena, Aristada (aripiprazole) dosing, indications ...。

Medscape - Bipolar disorder, schizophrenia, major depressive disorder-specific dosing for Abilify Maintena, Aristada (aripiprazole), frequency-based adverse ...： 。

Abilify Maintena | European Medicines Agency。

Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in ...： 。

[PDF] ABILIFY MAINTENA, INN-aripiprazole - European Medicines Agency |。

2013年11月15日 · Each pre-filled syringe contains 300 mg aripiprazole. Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection ...： 。

[PDF] ABILIFY MAINTENA - Accessdata.fda.gov。

See full prescribing information for ABILIFY MAINTENA. ABILIFY MAINTENA® (aripiprazole) for extended-release injectable suspension, for intramuscular use.：